Gouty Arthritis Market Forecast Insights: The Road To $5.06 Billion By 2030

Gouty Arthritis Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Gouty Arthritis Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The gouty arthritis market size has experienced robust expansion in recent years. It is projected to expand from $3.69 billion in 2025 to $3.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.2%. The historical expansion can be traced to evolving dietary patterns, the widespread availability of NSAIDs, a rise in arthritis diagnoses, the proliferation of rheumatology clinics, and advancements in pain management drug development.

The gouty arthritis market is projected to experience significant expansion in the coming years. Its valuation is expected to ascend to $5.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth throughout the forecast period can be attributed to elements such as an expanding aging population, heightened awareness of chronic diseases, a greater emphasis on preventive arthritis care, enhanced patient compliance, and personalized approaches to gout treatment. Furthermore, major developments anticipated during this period include an increasing prevalence of hyperuricemia, a growing demand for long-term disease management, the proliferation of combination drug therapies, improved adoption of diagnostic imaging techniques, and the expansion of lifestyle-based disease management strategies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=72039277&type=smp&name=Gouty%20Arthritis%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gouty Arthritis Market Demand Drivers: What’s Powering Industry Growth?

The escalating incidence of obesity is anticipated to stimulate the expansion of the gouty arthritis market in the future. Obesity is a medical condition defined by an excessive accumulation of body fat that compromises an individual’s health and is commonly evaluated using the body mass index (BMI). The increasing rate of obesity stems from a greater intake of high-calorie, processed foods and inactive lifestyles. Obesity contributes to gouty arthritis by augmenting the generation of uric acid and impairing the body’s capability to eliminate it, leading to the buildup of uric acid crystals in the joints. Moreover, surplus body weight imposes additional strain on joints, worsening the inflammation and discomfort associated with gout. For instance, in May 2025, as per the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, representing an increase from 64.0% reported in 2022 to 2023. Thus, the rising prevalence of obesity is propelling the growth of the gouty arthritis market.

Gouty Arthritis Market Segment Performance And Emerging Opportunities

The gouty arthritis market covered in this report is segmented –

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Other Treatments

3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

Gouty Arthritis Market Innovation Trends Shaping Future Development

Leading companies in the gouty arthritis market are intensifying their endeavors to develop innovative products, such as cortrophin gel, with the aim of delivering more effective and targeted treatments for managing the condition. Cortrophin gel, also known as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH). It is utilized to address various inflammatory and autoimmune conditions, including gouty arthritis. For example, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, obtained approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is designed for the adjunctive treatment of specific patients experiencing acute gouty arthritis flares. Cortrophin Gel is currently the exclusive FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for treating appropriate patients with acute gouty arthritis flares.

Gouty Arthritis Market Key Players: Which Companies Lead Industry Competition?

Major companies operating in the gouty arthritis market are Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, Protalix BioTherapeutics Inc

View The Full Gouty Arthritis Market Report:

https://thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gouty Arthritis Market Regional Analysis And Top Geography

North America was the largest region in the gouty arthritis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model